Literature DB >> 26501472

Risk Factors for Late-Onset Group B Streptococcal Disease Before and After Implementation of Universal Screening and Intrapartum Antibiotic Prophylaxis.

Jillian Pintye1, Babette Saltzman2, Elizabeth Wolf3,2, Claudia S Crowell3,4.   

Abstract

BACKGROUND: It is unclear whether risk factors for late-onset Group B Streptococcus disease (LOD) have changed since the introduction of universal screening and treatment in 2002.
METHODS: We conducted a case-control study using linked birth certificates and hospital discharge records. All infants born in Washington State from 1992 to 2011 and hospitalized between 7 and 89 days of life with a Group B Streptococcus (GBS)-related International Classification of Diseases (ICD)-9 code were included. Controls were matched 4:1 by birth year. Multivariate logistic regression was used to evaluate the association between clinical characteristics and LOD. We compared differences in the effect of risk factors on LOD between infants born before and after 2002 using likelihood ratio tests.
RESULTS: We identified 138 cases of LOD. In multivariate analyses, prematurity and young maternal age were significantly associated with risk of LOD throughout the study period; positive GBS screen was associated with LOD from 2003 to 2011. Each week of decreasing gestation was associated with a 1.24 (95% confidence interval: 1.15-1.35) times greater likelihood of LOD. We did not detect differences in the association between prematurity or young maternal age and LOD comparing infants born before and after 2002. Compared with infants of non-Hispanic white mothers, risk of LOD among infants of non-Hispanic black mothers decreased after 2002 (adjusted odds ratio [aOR] = 2.74 vs 0.64; pinteraction = 0.02), whereas risk of LOD among infants of Hispanic mothers increased (aOR = 0.80 vs 2.23; pinteraction ≤ 0.001).
CONCLUSIONS: Our results confirm studies conducted before 2002, which found that prematurity and young maternal age were associated with increased risk of LOD. Ethnicity-associated LOD risk differed before and after 2002, which may be related to healthcare access.
© The Author 2015. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Group B Streptococcus; antibiotics; late-onset disease; pediatrics

Mesh:

Year:  2015        PMID: 26501472      PMCID: PMC6280989          DOI: 10.1093/jpids/piv067

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  26 in total

1.  ACOG Committee Opinion: number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns.

Authors: 
Journal:  Obstet Gynecol       Date:  2002-12       Impact factor: 7.661

2.  Probable community acquisition of group B Streptococcus in an infant with late-onset disease: demonstration using field inversion gel electrophoresis.

Authors:  J D Trager; J M Martin; K Barbadora; M Green; E R Wald
Journal:  Arch Pediatr Adolesc Med       Date:  1996-07

3.  Streptococcus agalactiae late-onset neonatal infections: should breast milk be more systematically tested for bacterial contamination?

Authors:  Fanny Lombard; Hélène Marchandin; Aurélien Jacquot; Gilles Cambonie; Michel Rodière; Anne Filleron
Journal:  Acta Paediatr       Date:  2012-09-13       Impact factor: 2.299

4.  The Adequacy of Prenatal Care Utilization Index: its US distribution and association with low birthweight.

Authors:  M Kotelchuck
Journal:  Am J Public Health       Date:  1994-09       Impact factor: 9.308

5.  Group B streptococcus late-onset disease: 2003-2010.

Authors:  Alberto Berardi; Cecilia Rossi; Licia Lugli; Roberta Creti; Maria Letizia Bacchi Reggiani; Marcello Lanari; Luigi Memo; Maria Federica Pedna; Claudia Venturelli; Enrica Perrone; Matilde Ciccia; Elisabetta Tridapalli; Marina Piepoli; Raffaella Contiero; Fabrizio Ferrari
Journal:  Pediatrics       Date:  2013-01-06       Impact factor: 7.124

6.  Outbreak of late-onset group B Streptococcus in a neonatal intensive care unit.

Authors:  Jennifer K MacFarquhar; Timothy F Jones; Amy M Woron; Marion A Kainer; Cynthia G Whitney; Bernard Beall; Stephanie J Schrag; William Schaffner
Journal:  Am J Infect Control       Date:  2009-12-22       Impact factor: 2.918

7.  Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis.

Authors:  Hannah T Jordan; Monica M Farley; Allen Craig; Janet Mohle-Boetani; Lee H Harrison; Susan Petit; Ruth Lynfield; Ann Thomas; Shelley Zansky; Kenneth Gershman; Bernadette A Albanese; William Schaffner; Stephanie J Schrag
Journal:  Pediatr Infect Dis J       Date:  2008-12       Impact factor: 2.129

8.  Epidemiology of group B Streptococcus: longitudinal observations during pregnancy.

Authors:  B F Anthony; D M Okada; C J Hobel
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

9.  Breast milk transmission of group B streptococcal infection.

Authors:  Jürgen Dinger; Diane Müller; Nils Pargac; Roland Schwarze
Journal:  Pediatr Infect Dis J       Date:  2002-06       Impact factor: 2.129

10.  Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1996-05-31
View more
  5 in total

Review 1.  Group B Streptococcal Neonatal Meningitis.

Authors:  Teresa Tavares; Liliana Pinho; Elva Bonifácio Andrade
Journal:  Clin Microbiol Rev       Date:  2022-02-16       Impact factor: 50.129

Review 2.  Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.

Authors:  Miwako Kobayashi; Johan Vekemans; Carol J Baker; Adam J Ratner; Kirsty Le Doare; Stephanie J Schrag
Journal:  F1000Res       Date:  2016-09-22

3.  Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy.

Authors:  Shabir A Madhi; Anthonet Koen; Clare L Cutland; Lisa Jose; Niresha Govender; Frederick Wittke; Morounfolu Olugbosi; Ajoke Sobanjo-Ter Meulen; Sherryl Baker; Peter M Dull; Vas Narasimhan; Karen Slobod
Journal:  Clin Infect Dis       Date:  2017-11-13       Impact factor: 9.079

4.  Serotype distribution and incidence of invasive early onset and late onset group B streptococcal disease amongst infants in Singapore.

Authors:  Kai-Qian Kam; Koh Cheng Thoon; Wen Sim Nancy Tee; Michelle Lay Teng Ang; Natalie Woon Hui Tan; Kee Thai Yeo; Jiahui Li; Chia Yin Chong
Journal:  BMC Infect Dis       Date:  2021-12-07       Impact factor: 3.090

5.  Clinical Risk Factors Associated With Late-Onset Invasive Group B Streptococcal Disease: Systematic Review and Meta-Analyses.

Authors:  Konstantinos Karampatsas; Hannah Davies; Maren Mynarek; Nick Andrews; Paul T Heath; Kirsty Le Doare
Journal:  Clin Infect Dis       Date:  2022-09-30       Impact factor: 20.999

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.